We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-19.67%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.74B
AUM Growth
-$52.2M
Cap. Flow
+$616M
Cap. Flow %
22.46%
Top 10 Hldgs %
20.88%
Holding
327
New
27
Increased
203
Reduced
54
Closed
34

Top Buys

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$28.8M
2
WW
WW International
WW
+$26.6M
3
WIX icon
WIX.com
WIX
+$21.1M
4
PINC
Premier
PINC
+$20.4M
5
URBN icon
Urban Outfitters
URBN
+$19.1M

Top Sells

Rank Stock Value
1
CNDT icon
Conduent
CNDT
+$25.1M
2
DNOW icon
DNOW Inc
DNOW
+$18.7M
3
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
+$15.7M
4
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$14.9M
5
BECN
Beacon Roofing Supply, Inc.
BECN
+$14.5M

Sector Composition

Rank Sector Weight
1 Healthcare 22.84%
2 Industrials 19.01%
3 Technology 16.97%
4 Consumer Discretionary 11%
5 Communication Services 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTY
101
DELISTED
Party City Holdco Inc.
PRTY
$9.1M 0.33%
912,270
-490,428
-35% -$5.33M
LTHM
102
DELISTED
Livent Corporation
LTHM
$8.65M 0.32%
+627,138
New +$10.2M
CUB
103
DELISTED
Cubic Corporation
CUB
$8.53M 0.31%
+158,663
New +$10M
WLDN icon
104
Willdan Group
WLDN
$1.3B
$8.42M 0.31%
240,664
+64,946
+37% +$2.22M
OIS icon
105
Oil States International
OIS
$491M
$8.18M 0.3%
572,577
+7,139
+1% +$164K
PGNX
106
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$8.08M 0.29%
1,923,499
+578,239
+43% +$2.94M
MIXT
107
DELISTED
MIX TELEMATICS LIMITED
MIXT
$8.03M 0.29%
513,245
+169,492
+49% +$2.71M
PRIM icon
108
Primoris Services
PRIM
$4.45B
$7.79M 0.28%
+407,251
New +$9.14M
FCFS icon
109
FirstCash
FCFS
$8.78B
$7.78M 0.28%
107,569
+2,041
+2% +$163K
TDG icon
110
TransDigm Group
TDG
$67.7B
$7.59M 0.28%
22,333
+5,355
+32% +$1.84M
MEI icon
111
Methode Electronics
MEI
$592M
$7.32M 0.27%
314,235
-145,931
-32% -$4.12M
AKBA icon
112
Akebia Therapeutics
AKBA
$252M
$6.75M 0.25%
1,221,498
+1,181,278
+2,937% +$9.24M
OPTN
113
DELISTED
OptiNose
OPTN
$6.6M 0.24%
70,991
+35,129
+98% +$5.02M
MED icon
114
Medifast
MED
$141M
$6.16M 0.22%
49,269
+16,173
+49% +$2.77M
CNTY icon
115
Century Casinos
CNTY
$34M
$6.08M 0.22%
822,963
+280,425
+52% +$1.92M
BMRN icon
116
BioMarin Pharmaceuticals
BMRN
$12.4B
$5.88M 0.21%
69,080
+16,609
+32% +$1.58M
CSGP icon
117
CoStar Group
CSGP
$12.3B
$5.75M 0.21%
170,540
+40,910
+32% +$1.49M
ITRN icon
118
Ituran Location and Control
ITRN
$1.05B
$5.74M 0.21%
179,077
+59,345
+50% +$2M
FC icon
119
Franklin Covey
FC
$246M
$5.61M 0.2%
251,364
+83,653
+50% +$1.87M
IFF icon
120
International Flavors & Fragrances
IFF
$21.9B
$5.6M 0.2%
41,737
+10,142
+32% +$1.4M
TVTY
121
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$5.56M 0.2%
+224,146
New +$7.45M
INSM icon
122
Insmed
INSM
$28.6B
$5.39M 0.2%
411,074
+134,620
+49% +$2.15M
GRUB
123
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$5.24M 0.19%
34,092
+24,846
+269% +$4.66M
PCOM
124
DELISTED
Points.com Inc. Common Shares
PCOM
$5.18M 0.19%
520,487
+173,511
+50% +$2.06M
JAZZ icon
125
Jazz Pharmaceuticals
JAZZ
$16.7B
$5.15M 0.19%
41,534
+6,540
+19% +$970K
3 4
5
6 7

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Rice Hall James & Associates held 327 positions worth $2.74B, down 1.9% from $2.79B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Rice Hall James & Associates deployed $616M of net new capital in Q4 2018, opening 27 new positions and adding to 203 existing holdings. Its largest new stake was Myriad Genetics: 800,553 shares worth $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Coherent, an estimated $12.2M trimmed.

  • Rice Hall James & Associates's largest Q4 2018 buy was Myriad Genetics: 800,553 shares worth $23.3M.
  • Rice Hall James & Associates added most to WW International in Q4 2018, an estimated $26.6M increase.
  • Rice Hall James & Associates's biggest Q4 2018 reduction was Coherent, cutting an estimated $12.2M.
  • Rice Hall James & Associates fully exited Conduent in Q4 2018, selling an estimated $25.1M.
  • Rice Hall James & Associates's ten largest holdings make up 21% of its $2.74B portfolio in Q4 2018.
  • Rice Hall James & Associates opened 27 new positions and closed 34 in Q4 2018.
  • Rice Hall James & Associates's portfolio value fell 1.9% quarter-over-quarter to $2.74B.

Based on Rice Hall James & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.